The AHA yesterday asked the Centers for Medicare & Medicaid Services to withdraw a proposed rule that would further limit states’ ability to increase or create new pass-through payments for hospitals, physicians or nursing homes under Medicaid managed care contracts. In a May 6 final rule, CMS provided for a 10-year phase-out of pass through payments, beginning in 2017 and ending in 2027. However, in July the agency issued further guidance that states could not add new or increase current pass-through payment programs beyond what was included in their Medicaid managed care contracts on or before July 5, 2016. The proposed rule would codify this policy. “CMS has characterized that this rule is a clarification of its policy,” AHA Executive Vice President Tom Nickels wrote. “This proposed rule, however, changes, ‘the rules of the game’ mid-stream, leaving state Medicaid programs and hospitals no time to adjust, and the result could adversely affect hospitals dependent on these supplemental payments. Therefore, the AHA requests that CMS withdraw the proposed rule and allow states and hospitals the full 10-year transition period spelled out in the May 6, 2016 final rule, which begins in July 2017.”

Related News Articles

Headline
The Centers for Medicare & Medicaid Services April 19 approved an amendment to a Massachusetts Medicaid and Children’s Health Insurance Program…
Headline
One in five Medicaid enrollees have been disenrolled since continuous coverage ended last March, a quarter of whom remain uninsured, according to a poll…
Headline
The Centers for Medicare & Medicaid Services March 28 announced an extension of its temporary Marketplace special enrollment period for those who lost…
Headline
The Centers for Medicare & Medicaid Services March 15 announced flexibilities to help states initiate interim Medicaid payments to health care providers…
Headline
The Senate voted 75-22 on March 8 to pass and send to the president for his signature a package of six appropriations bills funding certain federal agencies…
Headline
The Centers for Medicare & Medicaid Services March 7 invited drug makers in the Medicaid Drug Rebate Program that make federally approved gene therapies…